The whole-of-society approach of mass COVID-19 vaccination in China: a qualitative study
Many countries have an inefficient vaccination system, which hinders global exit from the COVID-19 pandemic. It is vital to summarize COVID-19 vaccination practices in countries with high vaccination coverage and provide implications for other countries. This study aimed to investigate China's...
Saved in:
Published in | Health research policy and systems Vol. 20; no. 1; p. 142 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
30.12.2022
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Many countries have an inefficient vaccination system, which hinders global exit from the COVID-19 pandemic. It is vital to summarize COVID-19 vaccination practices in countries with high vaccination coverage and provide implications for other countries. This study aimed to investigate China's COVID-19 vaccination system and to summarize its implementation experience from a health system perspective.
We conducted key informant interviews in five representative cities of China in late 2021. Guided by the health systems framework proposed by WHO, we developed our interview guidelines which included seven building blocks-leadership and governance, health workforce, vaccination service delivery, vaccination mobilization and communication, financing, access to vaccines, and information systems. Semi-structured interviews and COVID-19 vaccination policy documents were collected and coded using a thematic analysis approach.
A total of 61 participants (nine vaccination programme directors of the local Center for Disease Control and Prevention, four government staff and 48 vaccination service workers) were interviewed. We found that China adopted a whole-of-society approach with adequate government engagement and linked health and non-health sectors to promote COVID-19 vaccination. Key measures included the collaboration of multiple systems and departments from a governance perspective, allocating sufficient health workers and resources, large-scale vaccination mobilization and communication, expansion of vaccine financing channels, localized production and digital information systems. With the vaccination system strengthening, the two-doses vaccination coverage reached 89.5% for the total population but relatively lower coverage for older adults as of July 2022.
Our study highlights the importance of a government-led whole-of-society approach to promote mass vaccination. The low vaccination coverage among older adults should be paid the greatest attention to. The experiences and lessons from China may serve as a reference for other countries. |
---|---|
AbstractList | Abstract Background Many countries have an inefficient vaccination system, which hinders global exit from the COVID-19 pandemic. It is vital to summarize COVID-19 vaccination practices in countries with high vaccination coverage and provide implications for other countries. This study aimed to investigate China’s COVID-19 vaccination system and to summarize its implementation experience from a health system perspective. Methods We conducted key informant interviews in five representative cities of China in late 2021. Guided by the health systems framework proposed by WHO, we developed our interview guidelines which included seven building blocks—leadership and governance, health workforce, vaccination service delivery, vaccination mobilization and communication, financing, access to vaccines, and information systems. Semi-structured interviews and COVID-19 vaccination policy documents were collected and coded using a thematic analysis approach. Results A total of 61 participants (nine vaccination programme directors of the local Center for Disease Control and Prevention, four government staff and 48 vaccination service workers) were interviewed. We found that China adopted a whole-of-society approach with adequate government engagement and linked health and non-health sectors to promote COVID-19 vaccination. Key measures included the collaboration of multiple systems and departments from a governance perspective, allocating sufficient health workers and resources, large-scale vaccination mobilization and communication, expansion of vaccine financing channels, localized production and digital information systems. With the vaccination system strengthening, the two-doses vaccination coverage reached 89.5% for the total population but relatively lower coverage for older adults as of July 2022. Conclusions Our study highlights the importance of a government-led whole-of-society approach to promote mass vaccination. The low vaccination coverage among older adults should be paid the greatest attention to. The experiences and lessons from China may serve as a reference for other countries. Many countries have an inefficient vaccination system, which hinders global exit from the COVID-19 pandemic. It is vital to summarize COVID-19 vaccination practices in countries with high vaccination coverage and provide implications for other countries. This study aimed to investigate China's COVID-19 vaccination system and to summarize its implementation experience from a health system perspective. We conducted key informant interviews in five representative cities of China in late 2021. Guided by the health systems framework proposed by WHO, we developed our interview guidelines which included seven building blocks--leadership and governance, health workforce, vaccination service delivery, vaccination mobilization and communication, financing, access to vaccines, and information systems. Semi-structured interviews and COVID-19 vaccination policy documents were collected and coded using a thematic analysis approach. A total of 61 participants (nine vaccination programme directors of the local Center for Disease Control and Prevention, four government staff and 48 vaccination service workers) were interviewed. We found that China adopted a whole-of-society approach with adequate government engagement and linked health and non-health sectors to promote COVID-19 vaccination. Key measures included the collaboration of multiple systems and departments from a governance perspective, allocating sufficient health workers and resources, large-scale vaccination mobilization and communication, expansion of vaccine financing channels, localized production and digital information systems. With the vaccination system strengthening, the two-doses vaccination coverage reached 89.5% for the total population but relatively lower coverage for older adults as of July 2022. Our study highlights the importance of a government-led whole-of-society approach to promote mass vaccination. The low vaccination coverage among older adults should be paid the greatest attention to. The experiences and lessons from China may serve as a reference for other countries. Many countries have an inefficient vaccination system, which hinders global exit from the COVID-19 pandemic. It is vital to summarize COVID-19 vaccination practices in countries with high vaccination coverage and provide implications for other countries. This study aimed to investigate China's COVID-19 vaccination system and to summarize its implementation experience from a health system perspective. We conducted key informant interviews in five representative cities of China in late 2021. Guided by the health systems framework proposed by WHO, we developed our interview guidelines which included seven building blocks-leadership and governance, health workforce, vaccination service delivery, vaccination mobilization and communication, financing, access to vaccines, and information systems. Semi-structured interviews and COVID-19 vaccination policy documents were collected and coded using a thematic analysis approach. A total of 61 participants (nine vaccination programme directors of the local Center for Disease Control and Prevention, four government staff and 48 vaccination service workers) were interviewed. We found that China adopted a whole-of-society approach with adequate government engagement and linked health and non-health sectors to promote COVID-19 vaccination. Key measures included the collaboration of multiple systems and departments from a governance perspective, allocating sufficient health workers and resources, large-scale vaccination mobilization and communication, expansion of vaccine financing channels, localized production and digital information systems. With the vaccination system strengthening, the two-doses vaccination coverage reached 89.5% for the total population but relatively lower coverage for older adults as of July 2022. Our study highlights the importance of a government-led whole-of-society approach to promote mass vaccination. The low vaccination coverage among older adults should be paid the greatest attention to. The experiences and lessons from China may serve as a reference for other countries. Background Many countries have an inefficient vaccination system, which hinders global exit from the COVID-19 pandemic. It is vital to summarize COVID-19 vaccination practices in countries with high vaccination coverage and provide implications for other countries. This study aimed to investigate China's COVID-19 vaccination system and to summarize its implementation experience from a health system perspective. Methods We conducted key informant interviews in five representative cities of China in late 2021. Guided by the health systems framework proposed by WHO, we developed our interview guidelines which included seven building blocks--leadership and governance, health workforce, vaccination service delivery, vaccination mobilization and communication, financing, access to vaccines, and information systems. Semi-structured interviews and COVID-19 vaccination policy documents were collected and coded using a thematic analysis approach. Results A total of 61 participants (nine vaccination programme directors of the local Center for Disease Control and Prevention, four government staff and 48 vaccination service workers) were interviewed. We found that China adopted a whole-of-society approach with adequate government engagement and linked health and non-health sectors to promote COVID-19 vaccination. Key measures included the collaboration of multiple systems and departments from a governance perspective, allocating sufficient health workers and resources, large-scale vaccination mobilization and communication, expansion of vaccine financing channels, localized production and digital information systems. With the vaccination system strengthening, the two-doses vaccination coverage reached 89.5% for the total population but relatively lower coverage for older adults as of July 2022. Conclusions Our study highlights the importance of a government-led whole-of-society approach to promote mass vaccination. The low vaccination coverage among older adults should be paid the greatest attention to. The experiences and lessons from China may serve as a reference for other countries. Keywords: COVID-19 vaccine, Mass vaccination, Vaccination system, Whole-of-society, Qualitative study, Interview BACKGROUNDMany countries have an inefficient vaccination system, which hinders global exit from the COVID-19 pandemic. It is vital to summarize COVID-19 vaccination practices in countries with high vaccination coverage and provide implications for other countries. This study aimed to investigate China's COVID-19 vaccination system and to summarize its implementation experience from a health system perspective. METHODSWe conducted key informant interviews in five representative cities of China in late 2021. Guided by the health systems framework proposed by WHO, we developed our interview guidelines which included seven building blocks-leadership and governance, health workforce, vaccination service delivery, vaccination mobilization and communication, financing, access to vaccines, and information systems. Semi-structured interviews and COVID-19 vaccination policy documents were collected and coded using a thematic analysis approach. RESULTSA total of 61 participants (nine vaccination programme directors of the local Center for Disease Control and Prevention, four government staff and 48 vaccination service workers) were interviewed. We found that China adopted a whole-of-society approach with adequate government engagement and linked health and non-health sectors to promote COVID-19 vaccination. Key measures included the collaboration of multiple systems and departments from a governance perspective, allocating sufficient health workers and resources, large-scale vaccination mobilization and communication, expansion of vaccine financing channels, localized production and digital information systems. With the vaccination system strengthening, the two-doses vaccination coverage reached 89.5% for the total population but relatively lower coverage for older adults as of July 2022. CONCLUSIONSOur study highlights the importance of a government-led whole-of-society approach to promote mass vaccination. The low vaccination coverage among older adults should be paid the greatest attention to. The experiences and lessons from China may serve as a reference for other countries. Abstract Background Many countries have an inefficient vaccination system, which hinders global exit from the COVID-19 pandemic. It is vital to summarize COVID-19 vaccination practices in countries with high vaccination coverage and provide implications for other countries. This study aimed to investigate China’s COVID-19 vaccination system and to summarize its implementation experience from a health system perspective. Methods We conducted key informant interviews in five representative cities of China in late 2021. Guided by the health systems framework proposed by WHO, we developed our interview guidelines which included seven building blocks—leadership and governance, health workforce, vaccination service delivery, vaccination mobilization and communication, financing, access to vaccines, and information systems. Semi-structured interviews and COVID-19 vaccination policy documents were collected and coded using a thematic analysis approach. Results A total of 61 participants (nine vaccination programme directors of the local Center for Disease Control and Prevention, four government staff and 48 vaccination service workers) were interviewed. We found that China adopted a whole-of-society approach with adequate government engagement and linked health and non-health sectors to promote COVID-19 vaccination. Key measures included the collaboration of multiple systems and departments from a governance perspective, allocating sufficient health workers and resources, large-scale vaccination mobilization and communication, expansion of vaccine financing channels, localized production and digital information systems. With the vaccination system strengthening, the two-doses vaccination coverage reached 89.5% for the total population but relatively lower coverage for older adults as of July 2022. Conclusions Our study highlights the importance of a government-led whole-of-society approach to promote mass vaccination. The low vaccination coverage among older adults should be paid the greatest attention to. The experiences and lessons from China may serve as a reference for other countries. |
ArticleNumber | 142 |
Audience | Academic |
Author | Hou, Zhiyuan Chen, Xi Wang, Qian Tu, Shiyi Qu, Zhiqiang |
Author_xml | – sequence: 1 givenname: Qian surname: Wang fullname: Wang, Qian organization: NHC Key Laboratory of Health Technology Assessment, Fudan University, Shanghai, China – sequence: 2 givenname: Zhiqiang surname: Qu fullname: Qu, Zhiqiang organization: NHC Key Laboratory of Health Technology Assessment, Fudan University, Shanghai, China – sequence: 3 givenname: Shiyi surname: Tu fullname: Tu, Shiyi organization: NHC Key Laboratory of Health Technology Assessment, Fudan University, Shanghai, China – sequence: 4 givenname: Xi surname: Chen fullname: Chen, Xi organization: Department of Economics, Yale University, City of New Haven, United States of America – sequence: 5 givenname: Zhiyuan orcidid: 0000-0003-3413-0076 surname: Hou fullname: Hou, Zhiyuan email: zyhou@fudan.edu.cn, zyhou@fudan.edu.cn organization: NHC Key Laboratory of Health Technology Assessment, Fudan University, Shanghai, China. zyhou@fudan.edu.cn |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36585666$$D View this record in MEDLINE/PubMed |
BookMark | eNptkttrFDEUxgep2Iv-Az5IwBd9mJr7xQehrLeFQkGr-BbOZpKdlNnJdjKzuv-92W4tXZA8JOfk933khO-0OupT76vqJcHnhGj5LhNqJKkxpTXGhqtaPalOCFe65gKLo0fn4-o05xtcSMPos-qYSaGFlPKk-nXdevS7TZ2vU6hzctGPWwTr9ZDAtSgFtIKc0ezq5_xjTQzagHOxhzGmHsUezdpSvEeAbifo4lj6G4_yODXb59XTAF32L-73s-rH50_Xs6_15dWX-ezisnZCmrEGrkxgVBrwQIwoZVDEUeGDgEYH8BozA0ooR5wsQ0qlG7yQhHJJnPPAzqr53rdJcGPXQ1zBsLUJor1rpGFpYRij67xloaGSgQTlHAcfDNeSL6hmjgnNm53Xh73XelqsfON8Pw7QHZge3vSxtcu0sUZjiikrBm_uDYZ0O_k82lXMzncd9D5N2VIljBFKYF7Q13t0CeVpsQ-pOLodbi8UI5oKwXGhzv9DldX4VXQlDiGW_oHg7YGgMKP_My5hytnOv387ZOmedUPKefDhYVKC7S5hdp8wW3Jj7xJmVRG9evxHD5J_kWJ_Aa24y08 |
CitedBy_id | crossref_primary_10_2139_ssrn_4819526 |
Cites_doi | 10.1007/s11366-020-09711-6 10.3390/vaccines9101071 10.1186/s43058-021-00184-z 10.1016/S0140-6736(21)00306-8 10.2196/27632 10.1016/j.jiph.2019.12.009 10.1016/S0140-6736(20)32642-8 10.2471/BLT.21.285616 10.1080/0142159X.2020.1755030 10.3389/fpubh.2021.756677 10.1001/jama.2020.8917 10.1371/currents.outbreaks.ce0f6177bc97332602a8e3fe7d7f7cc4 10.1111/nyas.12503 10.1186/s13584-021-00481-x 10.1016/j.vaccine.2022.01.059 10.1038/s41591-021-01454-y 10.1001/jama.2020.8711 10.3390/vaccines9050476 10.1038/s41577-021-00531-0 10.1016/S0140-6736(21)00617-6 10.1101/2021.07.23.21261013 10.3389/fpubh.2021.709127 10.1016/j.bjoms.2020.05.009 10.2147/RMHP.S338701 10.1186/s13584-021-00440-6 10.1186/s13584-021-00441-5 10.1007/s11366-012-9204-4 10.46234/ccdcw2021.157 10.46234/ccdcw2022.173 10.1080/14760584.2019.1574224 10.1080/10810730.2021.1884773 10.1186/s13584-021-00449-x 10.3390/vaccines9111329 10.4161/21645515.2014.969618 10.1016/j.jad.2020.08.059 |
ContentType | Journal Article |
Copyright | 2022. The Author(s). COPYRIGHT 2022 BioMed Central Ltd. The Author(s) 2022 |
Copyright_xml | – notice: 2022. The Author(s). – notice: COPYRIGHT 2022 BioMed Central Ltd. – notice: The Author(s) 2022 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION ISR 7X8 5PM DOA |
DOI | 10.1186/s12961-022-00947-7 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Gale In Context: Science MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 1478-4505 |
EndPage | 142 |
ExternalDocumentID | oai_doaj_org_article_3fd263a6a7cc4aef94864b283c3584da A731825540 10_1186_s12961_022_00947_7 36585666 |
Genre | Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GrantInformation_xml | – fundername: NIA NIH HHS grantid: K01 AG053408 |
GroupedDBID | --- -A0 0-V 0R~ 29I 2WC 3V. 44B 53G 5VS 7X7 7XC 88E 8C1 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAWTL ABDBF ABUWG ACGFO ACGFS ACHQT ACRMQ ADBBV ADINQ ADRAZ ADUKV AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS ALSLI AMKLP AMTXH AOIJS AQUVI ARALO ATCPS BAPOH BAWUL BCNDV BENPR BFQNJ BHPHI BMC BPHCQ BVXVI C24 C6C CCPQU CGR CS3 CUY CVF DIK DPSOV DU5 DWQXO E3Z EBD EBLON EBS ECM EIF ESX FAC FRP FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO IHR INH INR ISR ITC KC- KQ8 M0T M1P M2L M~E NPM O5R O5S OK1 P2P PATMY PGMZT PIMPY PQQKQ PROAC PSQYO PYCSY PZZ RBZ RNS ROL RPM RSV SMD SOJ TR2 TUS UKHRP UNMZH W2D WOQ WOW XSB ~8M AAYXX CITATION ABVAZ AFGXO AFNRJ 7X8 5PM |
ID | FETCH-LOGICAL-c569t-a479f3269aea195a47f71c25ef5ad8fae8039a757c1c6094678d0b612461ccea3 |
IEDL.DBID | RPM |
ISSN | 1478-4505 |
IngestDate | Tue Oct 22 14:53:57 EDT 2024 Tue Sep 17 21:30:36 EDT 2024 Fri Oct 25 04:27:21 EDT 2024 Thu Feb 22 23:41:30 EST 2024 Fri Feb 02 04:24:48 EST 2024 Sat Sep 28 21:38:35 EDT 2024 Thu Sep 12 17:39:40 EDT 2024 Sat Sep 28 08:17:34 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | COVID-19 vaccine Whole-of-society Qualitative study Vaccination system Mass vaccination Interview |
Language | English |
License | 2022. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c569t-a479f3269aea195a47f71c25ef5ad8fae8039a757c1c6094678d0b612461ccea3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-3413-0076 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802023/ |
PMID | 36585666 |
PQID | 2759957504 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_3fd263a6a7cc4aef94864b283c3584da pubmedcentral_primary_oai_pubmedcentral_nih_gov_9802023 proquest_miscellaneous_2759957504 gale_infotracmisc_A731825540 gale_infotracacademiconefile_A731825540 gale_incontextgauss_ISR_A731825540 crossref_primary_10_1186_s12961_022_00947_7 pubmed_primary_36585666 |
PublicationCentury | 2000 |
PublicationDate | 2022-12-30 |
PublicationDateYYYYMMDD | 2022-12-30 |
PublicationDate_xml | – month: 12 year: 2022 text: 2022-12-30 day: 30 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Health research policy and systems |
PublicationTitleAlternate | Health Res Policy Syst |
PublicationYear | 2022 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | J Schwartz (947_CR31) 2012; 17 GP Marchildon (947_CR15) 2021; 10 X Zhang (947_CR29) 2021; 26 B Trogen (947_CR4) 2020; 323 OJ Wouters (947_CR1) 2021; 397 JG Head (947_CR20) 1969; 28 947_CR22 Y Zhou (947_CR44) 2020; 277 Z Meng (947_CR39) 2021; 14 D Gong (947_CR45) 2021; 9 M Mckee (947_CR16) 2021; 10 JS Solís Arce (947_CR36) 2021; 27 947_CR24 RA Burgess (947_CR41) 2021; 397 F Oliani (947_CR13) 2022; 40 NA Addy (947_CR27) 2014; 1331 947_CR8 A Guignard (947_CR11) 2019; 18 D Levin-Zamir (947_CR33) 2020; 25 HJ Larson (947_CR37) 2015 KR Nehal (947_CR7) 2021; 9 S Shilo (947_CR35) 2021; 21 ME Kiger (947_CR21) 2020; 42 J Gao (947_CR30) 2021; 9 HJ Larson (947_CR43) 2014; 10 947_CR19 947_CR18 947_CR17 ET Tagoe (947_CR9) 2021; 9 Z Hou (947_CR6) 2021; 23 Y Qian (947_CR38) 2021; 3 H Liu (947_CR23) 2021 NP Sobers (947_CR25) 2021; 2 L The (947_CR2) 2021; 397 947_CR10 947_CR32 S Schaffer DeRoo (947_CR5) 2020; 323 L Gong (947_CR40) 2021; 9 B Rosen (947_CR12) 2021; 10 947_CR14 S Zang (947_CR42) 2022; 4 B Rosen (947_CR34) 2021; 10 AA Hyder (947_CR3) 2021; 99 SS Dubb (947_CR26) 2020; 58 I Wignjadiputro (947_CR28) 2020; 13 |
References_xml | – ident: 947_CR10 – volume: 26 start-page: 189 issue: 1 year: 2021 ident: 947_CR29 publication-title: J Chin Polit Sci doi: 10.1007/s11366-020-09711-6 contributor: fullname: X Zhang – volume: 9 start-page: 1071 issue: 10 year: 2021 ident: 947_CR7 publication-title: Vaccines doi: 10.3390/vaccines9101071 contributor: fullname: KR Nehal – volume: 2 start-page: 79 issue: 1 year: 2021 ident: 947_CR25 publication-title: Implement Sci Commun doi: 10.1186/s43058-021-00184-z contributor: fullname: NP Sobers – volume: 397 start-page: 1023 issue: 10278 year: 2021 ident: 947_CR1 publication-title: Lancet doi: 10.1016/S0140-6736(21)00306-8 contributor: fullname: OJ Wouters – volume: 23 issue: 6 year: 2021 ident: 947_CR6 publication-title: J Med Internet Res doi: 10.2196/27632 contributor: fullname: Z Hou – volume: 13 start-page: 994 issue: 7 year: 2020 ident: 947_CR28 publication-title: J Infect Public Health doi: 10.1016/j.jiph.2019.12.009 contributor: fullname: I Wignjadiputro – ident: 947_CR14 – volume: 397 start-page: 8 issue: 10268 year: 2021 ident: 947_CR41 publication-title: Lancet doi: 10.1016/S0140-6736(20)32642-8 contributor: fullname: RA Burgess – volume: 28 start-page: 214 issue: 2 year: 1969 ident: 947_CR20 publication-title: FinanzArchiv Public Finance Anal contributor: fullname: JG Head – volume: 99 start-page: 406-A issue: 6 year: 2021 ident: 947_CR3 publication-title: Bull World Health Organ doi: 10.2471/BLT.21.285616 contributor: fullname: AA Hyder – volume: 42 start-page: 846 issue: 8 year: 2020 ident: 947_CR21 publication-title: Med Teach doi: 10.1080/0142159X.2020.1755030 contributor: fullname: ME Kiger – volume: 9 year: 2021 ident: 947_CR30 publication-title: Front Public Health doi: 10.3389/fpubh.2021.756677 contributor: fullname: J Gao – volume: 323 start-page: 2460 issue: 24 year: 2020 ident: 947_CR4 publication-title: JAMA doi: 10.1001/jama.2020.8917 contributor: fullname: B Trogen – year: 2015 ident: 947_CR37 publication-title: PLoS Curr doi: 10.1371/currents.outbreaks.ce0f6177bc97332602a8e3fe7d7f7cc4 contributor: fullname: HJ Larson – volume: 1331 start-page: 216 year: 2014 ident: 947_CR27 publication-title: Ann N Y Acad Sci doi: 10.1111/nyas.12503 contributor: fullname: NA Addy – ident: 947_CR19 – volume: 10 start-page: 43 issue: 1 year: 2021 ident: 947_CR34 publication-title: Israel J Health Policy Res doi: 10.1186/s13584-021-00481-x contributor: fullname: B Rosen – volume: 40 start-page: 1397 issue: 10 year: 2022 ident: 947_CR13 publication-title: Vaccine doi: 10.1016/j.vaccine.2022.01.059 contributor: fullname: F Oliani – volume: 27 start-page: 1385 issue: 8 year: 2021 ident: 947_CR36 publication-title: Nat Med doi: 10.1038/s41591-021-01454-y contributor: fullname: JS Solís Arce – volume: 323 start-page: 2458 issue: 24 year: 2020 ident: 947_CR5 publication-title: JAMA doi: 10.1001/jama.2020.8711 contributor: fullname: S Schaffer DeRoo – volume: 9 start-page: 476 issue: 5 year: 2021 ident: 947_CR45 publication-title: Vaccines doi: 10.3390/vaccines9050476 contributor: fullname: D Gong – volume: 21 start-page: 198 issue: 4 year: 2021 ident: 947_CR35 publication-title: Nat Rev Immunol doi: 10.1038/s41577-021-00531-0 contributor: fullname: S Shilo – volume: 397 start-page: 941 issue: 10278 year: 2021 ident: 947_CR2 publication-title: Lancet doi: 10.1016/S0140-6736(21)00617-6 contributor: fullname: L The – year: 2021 ident: 947_CR23 publication-title: medRxiv doi: 10.1101/2021.07.23.21261013 contributor: fullname: H Liu – ident: 947_CR32 – ident: 947_CR8 – volume: 9 year: 2021 ident: 947_CR9 publication-title: Front Public Health doi: 10.3389/fpubh.2021.709127 contributor: fullname: ET Tagoe – volume: 58 start-page: 838 issue: 7 year: 2020 ident: 947_CR26 publication-title: Br J Oral Maxillofac Surg doi: 10.1016/j.bjoms.2020.05.009 contributor: fullname: SS Dubb – volume: 14 start-page: 4649 year: 2021 ident: 947_CR39 publication-title: Risk Manag Healthc Policy doi: 10.2147/RMHP.S338701 contributor: fullname: Z Meng – volume: 10 start-page: 6 issue: 1 year: 2021 ident: 947_CR12 publication-title: Isr J Health Policy Res doi: 10.1186/s13584-021-00440-6 contributor: fullname: B Rosen – ident: 947_CR17 – volume: 10 start-page: 5 issue: 1 year: 2021 ident: 947_CR16 publication-title: Isr J Health Policy Res doi: 10.1186/s13584-021-00441-5 contributor: fullname: M Mckee – volume: 17 start-page: 313 issue: 3 year: 2012 ident: 947_CR31 publication-title: J Chin Polit Sci doi: 10.1007/s11366-012-9204-4 contributor: fullname: J Schwartz – volume: 3 start-page: 645 issue: 30 year: 2021 ident: 947_CR38 publication-title: China CDC Wkly doi: 10.46234/ccdcw2021.157 contributor: fullname: Y Qian – ident: 947_CR22 – ident: 947_CR18 – volume: 4 start-page: 832 issue: 37 year: 2022 ident: 947_CR42 publication-title: China CDC Wkly doi: 10.46234/ccdcw2022.173 contributor: fullname: S Zang – volume: 18 start-page: 119 issue: 2 year: 2019 ident: 947_CR11 publication-title: Expert Rev Vaccines doi: 10.1080/14760584.2019.1574224 contributor: fullname: A Guignard – ident: 947_CR24 – volume: 25 start-page: 816 issue: 10 year: 2020 ident: 947_CR33 publication-title: J Health Commun doi: 10.1080/10810730.2021.1884773 contributor: fullname: D Levin-Zamir – volume: 10 start-page: 12 issue: 1 year: 2021 ident: 947_CR15 publication-title: Isr J Health Policy Res doi: 10.1186/s13584-021-00449-x contributor: fullname: GP Marchildon – volume: 9 start-page: 1329 issue: 11 year: 2021 ident: 947_CR40 publication-title: Vaccines doi: 10.3390/vaccines9111329 contributor: fullname: L Gong – volume: 10 start-page: 2543 issue: 9 year: 2014 ident: 947_CR43 publication-title: Hum Vaccines Immunother doi: 10.4161/21645515.2014.969618 contributor: fullname: HJ Larson – volume: 277 start-page: 510 year: 2020 ident: 947_CR44 publication-title: J Affect Disord doi: 10.1016/j.jad.2020.08.059 contributor: fullname: Y Zhou |
SSID | ssj0022932 |
Score | 2.3599086 |
Snippet | Many countries have an inefficient vaccination system, which hinders global exit from the COVID-19 pandemic. It is vital to summarize COVID-19 vaccination... Abstract Background Many countries have an inefficient vaccination system, which hinders global exit from the COVID-19 pandemic. It is vital to summarize... Background Many countries have an inefficient vaccination system, which hinders global exit from the COVID-19 pandemic. It is vital to summarize COVID-19... BACKGROUNDMany countries have an inefficient vaccination system, which hinders global exit from the COVID-19 pandemic. It is vital to summarize COVID-19... Abstract Background Many countries have an inefficient vaccination system, which hinders global exit from the COVID-19 pandemic. It is vital to summarize... |
SourceID | doaj pubmedcentral proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 142 |
SubjectTerms | Aged Analysis China COVID-19 - prevention & control COVID-19 vaccine COVID-19 Vaccines Epidemics Humans Interview Mass vaccination Pandemics Qualitative study Vaccination Vaccination system Vaccines Whole-of-society |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT5UQ4k2gVAYhcUBW8_Aj5tYWqhYJkICivVljx4Y9kCCyW_4-YzupNuLAhWPiOcQzY8830cw3hLywVahaKSqGoUCw6CEMIDTMonvpDiEp6Njv_P6DPL_k71ZitTPqK9aEZXrgrLijJnS1bECCco6DD5q3klsMiq7B2NllaFTqOZmaUi0MYvXcItPKoxGjmsS0GROvWEqnmFqEocTW__edvBOUlgWTOxHo7Da5NUFHepw_-Q654fu75Gb-70ZzO9E9skK7099x6C0bAhtzTSadmcPpEOgPhMv09OPXizes0vQKnFvnP4J03dM0Tvs1BZqbLRMrOE0UtPfJ5dnbL6fnbJqewJyQesOAKx0QnGnwUGmBj0FVrhY-COjaAL4tGw1KKFc5iUrBqNWVFgEPl5VzHpoHZK8fev-IUAtcQiU8tKrjKGuF4421HKGN67SvC_JqVqb5mUkyTEouWmmy6g2q3iTVG1WQk6jva8lIcJ1eoNnNZHbzL7MX5Hm0lokUFn2skfkG23E0F58_mWOF9xRmSrwsyMtJKAxoNwdTywHuKrJeLSQPFpJ4xtxi-dnsFCYuxcK03g_b0dQqMrZFjvyCPMxOcr2xBtEdomVZELVwn8XOlyv9-nui-NZtGefaP_4fqnpC9uvo-ZGdsjwge5tfW_8UkdTGHqZD8wdPZxlQ priority: 102 providerName: Directory of Open Access Journals |
Title | The whole-of-society approach of mass COVID-19 vaccination in China: a qualitative study |
URI | https://www.ncbi.nlm.nih.gov/pubmed/36585666 https://search.proquest.com/docview/2759957504 https://pubmed.ncbi.nlm.nih.gov/PMC9802023 https://doaj.org/article/3fd263a6a7cc4aef94864b283c3584da |
Volume | 20 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELa28YKEEL8XGJVBSDwgr03iHzFva9m0IW1Mg6GKF-vi2KMSTaa1hX-fs5NMi3jjJVLrq1SfP-e-s-4-E_KuTH1aSJEyDAWCBYQwAJ-zEuGlK6SkoEO_8-mZPL7kn-divkVE3wsTi_Ztudivfy3368XPWFt5vbTjvk5sfH4608Uk3Po93ibbCNA-Re-yLIxfWd8dU8jxCgOaxIwZc65QRaeYGkSgKNT_7-v4Tjwa1kreCT5Hj8jDjjXSg_bfPSZbrn5CHrRHbrTtJHpK5rjk9E-475Y1nq3ackzai4bTxtMlMmU6-_L95BNLNf0N1i7aw0C6qGm8SfsjBdr2WUZBcBrVZ5-Ry6PDb7Nj1l2cwKyQes2AK-2Rl2lwkGqBH71KbSacF1AVHlwxyTUooWxqJToFA1Y1KZHrcJla6yB_Tnbqpna7hJbAJaTCQaEqjralsDwvS46sxlbaZQn50DvTXLf6GCbmFYU0resNut5E1xuVkGnw961l0LaOXzQ3V6ZbYZP7KpM5SFDWcnBe80LyEmmQzZEtVZCQt2G1TFCvqEN5zBVsVitz8vXCHCh8RWGSxCcJed8Z-QbXzULXbYCzCoJXA8u9gSVuLzsYftODwoShUJNWu2azMpkKYm1BHj8hL1qQ3E4sR2KHRFkmRA3gM5j5cATBHtW9O3C__O9fviL3swD3oEY52SM765uNe43MaV2OcL_MFT6LWToi96aHZ-cXo3gKgc-L6Y9R3El_AV2OHM8 |
link.rule.ids | 230,315,730,783,787,867,888,2109,27936,27937,31732,33279,33757,53804,53806 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKOYCEeD8CBQxC4oC8m4cfCbeyUO1CtyBoq71ZtmOXFWxSNbsg8esZO0nVwAmOiSdSnPmc-caa-YzQC524JOcsIRAKGPEIIUq5jGiAV1ECJVWF73eeH_DpEX2_YIstxPpemFC0b_RyVH1fjarl11Bbeboy475ObPxpPiny2J_6Pb6ELsN6jWmfpHd5FkSwtO-Pyfm4gZDGIWeGrMvX0QkiBjEoSPX__UO-EJGG1ZIXws_eDXTcv3hbdfJttFnrkfn1h6bjP8_sJrreEVK82w7fQlu2uo2utbt5uG1SuoMWgCb80x-lS2pHmrbSE_d65Lh2eAUkHE8-Hs_ekqTAP5Qxy3afES8rHA7pfo0Vbls4g9Y4DsK2d9HR3rvDyZR0ZzIQw3ixJoqKwgHlK5RVScHg0onEpMw6psrcKZvHWaEEEyYxHL42xMIy1kCjKE-MsSq7h7arurIPENaKcpUwq3JRUrDVzNBMawqEyZSFTSP0qveSPG2lN2RIWXIuW59K8KkMPpUiQm-8I88tvWx2uFGfncjuE8vMlSnPFFfCGKqsK2jOqQaGZTIgYqWK0HMPA-mFMSpfeXOiNk0jZ18-y10Bfz_Iv2gcoZedkasBEEZ1jQwwK6-lNbDcGVjCyjWD4Wc92qQf8uVula03jUyF14HzyvsRut-i73xiGXBG4OA8QmKAy8HMhyOAtiAc3qHr4X8_-RRdmR7O9-X-7ODDI3Q19WvKi17GO2h7fbaxj4GgrfWTsBx_A7UtOWs |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELZgSAgJ8RsWGGAQEg_IbX44dszb6KhWYGMCNlW8WLZjbxU0qdYWJP56zk4yNfC2x9RXKc59zn0X3X2H0CuduKRgeUIgFOTEI4Qo5TKiAV6iBEqqhO93Pjhk-8f0wzSfboz6CkX7Rs8G1c_5oJqdhdrKxdwMuzqx4dHBSBSxn_o9XJRueBVdgzMbsy5Rb3MtiGJp1yNTsOESwhqDvBkyL19LxwnvxaEg1___S3kjKvUrJjdC0Pg2-t7dfFN58mOwXumB-fOPruOldncH3WqJKd5tTO6iK7a6h242X_Vw06x0H00BVfi3H6lLakeWTcUn7nTJce3wHMg4Hn0-meyRROBfyphZ870RzyochnW_xQo3rZxBcxwHgdsH6Hj8_tton7SzGYjJmVgRRblwQP2EsioROVw6npg0ty5XZeGULeJMKJ5zkxgGTxxiYhlroFOUJcZYlT1EW1Vd2W2EtaJMJblVBS8p2Orc0ExrCsTJlMKmEXrTeUouGgkOGVKXgsnGrxL8KoNfJY_QO-_MC0svnx1-qM9PZfuYZebKlGWKKW4MVdYJWjCqgWmZDAhZqSL00kNBeoGMylfgnKr1ciknX7_IXQ5vQcjDaByh162RqwEURrUNDbArr6nVs9zpWcIJNr3lFx3ipF_yZW-VrddLmXKvB-cV-CP0qEHgxcYy4I7AxVmEeA-bvZ33VwBxQUC8RdjjS__zObp-tDeWnyaHH5-gG6k_Vl77Mt5BW6vztX0KPG2ln4UT-ReC9Tvr |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+whole-of-society+approach+of+mass+COVID-19+vaccination+in+China%3A+a+qualitative+study&rft.jtitle=Health+research+policy+and+systems&rft.au=Wang%2C+Qian&rft.au=Qu%2C+Zhiqiang&rft.au=Tu%2C+Shiyi&rft.au=Chen%2C+Xi&rft.date=2022-12-30&rft.pub=BioMed+Central+Ltd&rft.issn=1478-4505&rft.eissn=1478-4505&rft.volume=20&rft.issue=1&rft_id=info:doi/10.1186%2Fs12961-022-00947-7&rft.externalDBID=ISR&rft.externalDocID=A731825540 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1478-4505&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1478-4505&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1478-4505&client=summon |